-
1
-
-
0027273479
-
Cytotoxic chemotherapy for advanced renal cell carcinoma
-
Yagoda A, Petrylak D, Thompson S. Cytotoxic chemotherapy for advanced renal cell carcinoma. Urol Clin N Amer 1993;20:303-21.
-
(1993)
Urol Clin N Amer
, vol.20
, pp. 303-321
-
-
Yagoda, A.1
Petrylak, D.2
Thompson, S.3
-
2
-
-
0024205702
-
The role of biological response modifiers in metastatic renal carcinoma
-
Muss HB. The role of biological response modifiers in metastatic renal carcinoma. Sem Surg Onc 1988;15(Suppl.5):30-4.
-
(1988)
Sem Surg Onc
, vol.15
, Issue.SUPPL. 5
, pp. 30-34
-
-
Muss, H.B.1
-
3
-
-
0023749717
-
Biologic Response Modifiers in metastatic renal carcinoma
-
Quesada JR. Biologic Response Modifiers in metastatic renal carcinoma. Sem Onc 1988;15:396-407.
-
(1988)
Sem Onc
, vol.15
, pp. 396-407
-
-
Quesada, J.R.1
-
4
-
-
0023115642
-
A progress report on the treatment of 157 patients with advanced cancer using lymphocyteactivated killer cells and interleukin-2 or high dose interleukin-2 alone
-
Rosenberg SA, Lotze MT, Muul LM, et al. A progress report on the treatment of 157 patients with advanced cancer using lymphocyteactivated killer cells and interleukin-2 or high dose interleukin-2 alone. N Engl J Med 1987;316:889-97.
-
(1987)
N Engl J Med
, vol.316
, pp. 889-897
-
-
Rosenberg, S.A.1
Lotze, M.T.2
Muul, L.M.3
-
5
-
-
7144248725
-
Plant antitumor agents. 1. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata
-
Wall ME, Wani MC, Cook CE, Palmer KH, MCPhail AT, Sim GA. Plant antitumor agents. 1. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J Am Chem Soc 1966;88:3888-90.
-
(1966)
J Am Chem Soc
, vol.88
, pp. 3888-3890
-
-
Wall, M.E.1
Wani, M.C.2
Cook, C.E.3
Palmer, K.H.4
McPhail, A.T.5
Sim, G.A.6
-
6
-
-
0015150039
-
Studies on camptothecin: 1. Effects on nucleic acid and protein synthesis
-
Horwitz SB, Chang CSCK, Grollman AP. Studies on camptothecin: 1. Effects on nucleic acid and protein synthesis. Mol. Pharmacol 1971;7:632-44.
-
(1971)
Mol. Pharmacol
, vol.7
, pp. 632-644
-
-
Horwitz, S.B.1
Chang, C.S.C.K.2
Grollman, A.P.3
-
7
-
-
0023924786
-
Identification of mammalian DNA topoisomerase 1 as an intracellular target of the anticancer drug Camptothecin
-
Hsiang YH, Liu LF. Identification of mammalian DNA topoisomerase 1 as an intracellular target of the anticancer drug Camptothecin. Cancer Res 1988;48:1722-6.
-
(1988)
Cancer Res
, vol.48
, pp. 1722-1726
-
-
Hsiang, Y.H.1
Liu, L.F.2
-
8
-
-
0023552964
-
Antitumor activity of 7-ethyl-10-[4-( 1-piperidino)-1-piperidino] carbonyloxycamptothecin, against murine tumors
-
Kunimoto T, Nitta K, Tanaka T, et al. Antitumor activity of 7-ethyl-10-[4-( 1-piperidino)-1-piperidino]carbonyloxycamptothecin, against murine tumors. Cancer Res 1987;47:5944-7.
-
(1987)
Cancer Res
, vol.47
, pp. 5944-5947
-
-
Kunimoto, T.1
Nitta, K.2
Tanaka, T.3
-
9
-
-
33644569988
-
Camptothecin analogues and Cisplatin: An effective therapy of advanced human bladder cancer
-
Amsterdam: European Cancer Center
-
Keane TE, Petros JA, McGuire W, et al. Camptothecin analogues and Cisplatin: An effective therapy of advanced human bladder cancer. Abst#59 6th conference on DNA Topoisomerases in therapy. Amsterdam: European Cancer Center, 1995.
-
(1995)
Abst#59 6th Conference on DNA Topoisomerases in Therapy
-
-
Keane, T.E.1
Petros, J.A.2
McGuire, W.3
-
10
-
-
0026531753
-
A phase 11 study of CPT-11, a new derivative of camptothecin, for previously untreated non small cell lung cancer
-
Fukuoka M, Niitani H, Suzuki A, et al. A phase 11 study of CPT-11, a new derivative of camptothecin, for previously untreated non small cell lung cancer. J Clin Oncol 1992;10:16-20.
-
(1992)
J Clin Oncol
, vol.10
, pp. 16-20
-
-
Fukuoka, M.1
Niitani, H.2
Suzuki, A.3
-
11
-
-
0000107302
-
Phase 11 study of CPT-11, a new camptothecin derivative, in small cell lung cancer
-
Negoro S, Fukuoka M, Niitani H, Taguchi T. Phase 11 study of CPT-11, a new camptothecin derivative, in small cell lung cancer. Proc Am Soc Clin Oncol 1991;10:241.
-
(1991)
Proc Am Soc Clin Oncol
, vol.10
, pp. 241
-
-
Negoro, S.1
Fukuoka, M.2
Niitani, H.3
Taguchi, T.4
-
12
-
-
0027813132
-
In vitro and in vivo effects of clinically important camptothecin analogues on multidrug resistant cells
-
Marren MR, Hoffman GA, Polsky RM, Funk LR, McCabe FL, Johnson RK. In vitro and in vivo effects of clinically important camptothecin analogues on multidrug resistant cells. Oncol Res 1993; 5:467-74.
-
(1993)
Oncol Res
, vol.5
, pp. 467-474
-
-
Marren, M.R.1
Hoffman, G.A.2
Polsky, R.M.3
Funk, L.R.4
McCabe, F.L.5
Johnson, R.K.6
-
13
-
-
0025194067
-
Dipyridamole-cisplatin potentiation: Enhanced in vivo cytotoxicity in xenograft models of human testicular and bladder cancers
-
Keane TE, Rosner G, Donaldson JT, Norwood DL, Poulton SH, Walther PJ. Dipyridamole-cisplatin potentiation: enhanced in vivo cytotoxicity in xenograft models of human testicular and bladder cancers. J Urol 1990;144:1004-9.
-
(1990)
J Urol
, vol.144
, pp. 1004-1009
-
-
Keane, T.E.1
Rosner, G.2
Donaldson, J.T.3
Norwood, D.L.4
Poulton, S.H.5
Walther, P.J.6
-
14
-
-
0002895992
-
A rapid screening method for testing chemotherapeutic agents human tumor xenografts
-
Houchens DP, Ovejera AA, editors. New York: Gustav Fisher
-
Bogden AE, Kelton DE, Cobb WR, Esber HJ. A rapid screening method for testing chemotherapeutic agents human tumor xenografts. In: Houchens DP, Ovejera AA, editors. Proceedings of the symposium on the use of athymic (nude) mice in cancer research. New York: Gustav Fisher, 1978. pp 231-250.
-
(1978)
Proceedings of the Symposium on the Use of Athymic (Nude) Mice in Cancer Research
, pp. 231-250
-
-
Bogden, A.E.1
Kelton, D.E.2
Cobb, W.R.3
Esber, H.J.4
-
15
-
-
0021544086
-
Predictive testing with the subrenal capsule assay
-
Bogden AE, Griffin W, Reich SD, Costanza ME, Cobb WR. Predictive testing with the subrenal capsule assay. Cancer Treat Rev 1984;11(suppl A): 113-24.
-
(1984)
Cancer Treat Rev
, vol.11
, Issue.SUPPL. A
, pp. 113-124
-
-
Bogden, A.E.1
Griffin, W.2
Reich, S.D.3
Costanza, M.E.4
Cobb, W.R.5
-
16
-
-
0028054890
-
Combination versus single agent therapy in effecting complete therapeutic response in human bladder cancer: Analysis of cisplatin and/or 5-fluorouracil in an in vivo survival model
-
Keane TE, Gingrich JR, Rosner G, Webb KS, Poulton SH, Walther PJ. Combination versus single agent therapy in effecting complete therapeutic response in human bladder cancer: analysis of cisplatin and/or 5-fluorouracil in an in vivo survival model. Cancer Res 1994; 54:475-81.
-
(1994)
Cancer Res
, vol.54
, pp. 475-481
-
-
Keane, T.E.1
Gingrich, J.R.2
Rosner, G.3
Webb, K.S.4
Poulton, S.H.5
Walther, P.J.6
-
19
-
-
0024329881
-
The biochemistry of P-glycoprotein mediated multi drug resistance
-
Endicott JA, Ling V. The biochemistry of P-glycoprotein mediated multi drug resistance. Annu Rev Biochem 1989;58:137-71.
-
(1989)
Annu Rev Biochem
, vol.58
, pp. 137-171
-
-
Endicott, J.A.1
Ling, V.2
-
20
-
-
0024779132
-
P-glycoprotein multidrug resistance and a superfamily of membrane associated transport proteins
-
Juranka PF, Zastawny RL, Ling V. P-glycoprotein multidrug resistance and a superfamily of membrane associated transport proteins. FASEB J 1989;3:2583-92.
-
(1989)
FASEB J
, vol.3
, pp. 2583-2592
-
-
Juranka, P.F.1
Zastawny, R.L.2
Ling, V.3
-
21
-
-
0022496762
-
Misonidazole induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl- 1-nitrosurea toxicity in 06 methylguanine-DNA methyltransferase proficient (mer+) and deficient (mer-) cell lines
-
Mulcahy RT. Misonidazole induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosurea toxicity in 06 methylguanine-DNA methyltransferase proficient (mer+) and deficient (mer-) cell lines. Cancer Res 1986;46:2892-7.
-
(1986)
Cancer Res
, vol.46
, pp. 2892-2897
-
-
Mulcahy, R.T.1
-
22
-
-
0029960812
-
Eukaryotic DNA Topoisomerase 1: Genome Gatekeeper and its intruders, Camptothecins
-
Pommier Y. Eukaryotic DNA Topoisomerase 1: Genome Gatekeeper and its intruders, Camptothecins. Seminars in Oncology 1996; 23(suppl 3):3-10.
-
(1996)
Seminars in Oncology
, vol.23
, Issue.SUPPL. 3
, pp. 3-10
-
-
Pommier, Y.1
-
24
-
-
0027324850
-
Therapeutic efficacy of the topoisomerase 1 inhibitor 7-ethyl-10(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: Lack of cross resistance in vivo in tumors with acquired resistance to the topoisomerase 1 inhibitor 9-dimethylaminomethyl-10- hydroxycamptothecin
-
Houghton PJ, Cheshire PJ, Hallman JC, Bissery MC, Mathieu-Boue A, Houghton JD. Therapeutic efficacy of the topoisomerase 1 inhibitor 7-ethyl-10(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross resistance in vivo in tumors with acquired resistance to the topoisomerase 1 inhibitor 9-dimethylaminomethyl-10- hydroxycamptothecin. Ca Res 1993;53: 2823-9.
-
(1993)
Ca Res
, vol.53
, pp. 2823-2829
-
-
Houghton, P.J.1
Cheshire, P.J.2
Hallman, J.C.3
Bissery, M.C.4
Mathieu-Boue, A.5
Houghton, J.D.6
-
25
-
-
0027471350
-
Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between nontumorigenic and tumorigenic cells in vitro
-
Pantazis P, Kozielski AJ, Mendoza JT, Early JA, Hinz HR, Giovanella BC. Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between nontumorigenic and tumorigenic cells in vitro. Int J Cancer 1993;53: 863-71.
-
(1993)
Int J Cancer
, vol.53
, pp. 863-871
-
-
Pantazis, P.1
Kozielski, A.J.2
Mendoza, J.T.3
Early, J.A.4
Hinz, H.R.5
Giovanella, B.C.6
-
26
-
-
0022340594
-
Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase1
-
Hsiang YH, Hertzberg R, Hecht S, Lui L. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase1. J Biol Chem 1985;260:14873-8.
-
(1985)
J Biol Chem
, vol.260
, pp. 14873-14878
-
-
Hsiang, Y.H.1
Hertzberg, R.2
Hecht, S.3
Lui, L.4
-
27
-
-
0031755364
-
Improved survival in patients with advanced colorectal carcinoma failing 5-fluorouracil who received irinotecan hydrochloride and have high intratumor C-fos expression
-
Singh A, Tong A, Ognoskie N, Meyer W, Nemunaitis J. Improved survival in patients with advanced colorectal carcinoma failing 5-fluorouracil who received irinotecan hydrochloride and have high intratumor C-fos expression. Am J Clin Oncol 1998;21(5):466-9.
-
(1998)
Am J Clin Oncol
, vol.21
, Issue.5
, pp. 466-469
-
-
Singh, A.1
Tong, A.2
Ognoskie, N.3
Meyer, W.4
Nemunaitis, J.5
-
28
-
-
0035890465
-
Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients
-
Becouarn Y, Gamelin E, Coudert B, et al. Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients. J Clin Oncol 2001;19:4195-201.
-
(2001)
J Clin Oncol
, vol.19
, pp. 4195-4201
-
-
Becouarn, Y.1
Gamelin, E.2
Coudert, B.3
-
29
-
-
0035873927
-
Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer
-
Kemeny N, Gonen M, Sullivan D, et al. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol 2001;19:2687-95.
-
(2001)
J Clin Oncol
, vol.19
, pp. 2687-2695
-
-
Kemeny, N.1
Gonen, M.2
Sullivan, D.3
|